#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Spartalizumab and Pazopanib for Patients with Refractory or Recurrent Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Safety and Effectiveness of Pembrolizumab, Favezelimab, and Vibostolimab for Children and Young Adults with Blood Cancers or Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on Dostarlimab to Prevent Second Cancer in Patients Cured from Primary Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • A study to evaluate the safety and effectiveness of KD033 in patients with advanced or metastatic solid tumors

    Not recruiting

    1 1 1
    France Spain

  • A Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark Estonia Greece Italy +2

  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Study of DCC-3084 alone and with other cancer drugs in patients with advanced solid tumors driven by the MAPK pathway

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Spain

  • Study on the Safety and Effects of GSK4418959 and Dostarlimab for Adults with Colorectal Cancer with Mismatch Repair Deficiency or High Microsatellite Instability

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium The Netherlands Spain

  • Study on Niraparib and Dostarlimab for Patients with DNA Repair-Deficient or Platinum-Sensitive Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Safety and Effects of RP-1664 for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark